What is the best next treatment for an adult with inoperable residual squamous‑cell lung carcinoma, PD‑L1 70% positive, after four cycles of pembrolizumab (Keytruda) plus gemcitabine and cisplatin, with ECOG 0‑2 and adequate organ function?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: February 6, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What percentage of non-small cell lung cancer (NSCLC) patients present with metastatic disease at diagnosis?

What are the treatment options for advanced non-small cell lung cancer (NSCLC) using immunotherapy, such as pembrolizumab (pembrolizumab) or nivolumab (nivolumab)?

What is the recommended first-line treatment for a patient with advanced non-small cell lung cancer (NSCLC), considering therapies such as pembrolizumab?

What are the initial treatment options for non-small cell lung cancer?

What is the basic information for a patient regarding Pembrolizumab (pembrolizumab)?

In a young woman with acute eye pain and no conjunctival redness, what is the most likely diagnosis and what urgent management is recommended?

What are the maternal and fetal risks of taking ibuprofen once daily during the second trimester of pregnancy for severe pain?

What investigations should be performed to evaluate suspected distal (type 1) renal tubular acidosis?

What is the recommended treatment for a previously healthy 6‑year‑old boy with confirmed or suspected influenza A?

In a smoker with a cold thyroid nodule, poorly defined ultrasound margins, unilateral cervical lymphadenopathy, dysphagia, hoarseness, fatigue, and loss of appetite, what is the most likely diagnosis and what diagnostic work‑up and treatment plan should be pursued?

What is the recommended duration and dosing schedule of oral vancomycin for a first episode of Clostridioides difficile infection and for first or subsequent recurrences?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.